✦ LIBER ✦

Possible enhancement of the cardiotoxicity of doxorubicin when combined with mitomycin C

✍ Scribed by Fabrizio Villani; Roberto Comazzi; Gemma Lacaita; Antonio Guindani; Valerio Genitoni; Alberto Volonterio; Maria Cristina Brambilla

Book ID: 112944216
Publisher: Springer US
Year: 1985
Tongue: English
Weight: 388 KB
Volume: 2
Category: Article
ISSN: 1357-0560
DOI: 10.1007/bf02934854

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Flavone acetic acid increases the cytoto

Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia

✍ H. Takeuchi; Hideo Baba; Yoshihiko Maehara; Keizo Sugimachi; Robert A Newman 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 210 KB

Induction of DT-diaphorase by doxorubici

Induction of DT-diaphorase by doxorubicin and combination therapy with mitomycin C in vitro

✍ Asher Begleiter; Marsha K. Leith 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 653 KB

Enhanced antitumor activity of irofulven

Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C

✍ Michael J. Kelner; Trevor C. McMorris; Rafael J. Rojas; Nicole A. Trani; Leita E 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 135 KB

In vitro toxicity to breast cancer cells

In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin

✍ Richard Y. Cheung; Andrew M. Rauth; Patrick T. Ronaldson; Reina Bendayan; Xiao Y 📂 Article 📅 2006 🏛 Elsevier Science 🌐 French ⚖ 307 KB

Possible use of combination chemotherapy

Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes

✍ Masahiko Tanabe; Yoshinori Ito; Nahomi Tokudome; Tsutomu Sugihara; Hiroyoshi Miu 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 174 KB

Chemotherapy for hormonally refractory a

Chemotherapy for hormonally refractory advanced prostate carcinoma. A Comparison of combined versus sequential treatment with mitomycin C, doxorubicin, and 5-fluorouracil

✍ John A. Laurie; Richard G. Hahn; Terry M. Therneau; Shreyaskumar R. Patel; James 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB 👁 2 views

One hundred forty-two patients with progressive, hormonally refractory advanced prostate carcinoma who had not received prior chemotherapy were randomized to receive either combination chemotherapy with 5-fluorouracil(5-FU), doxorubicin, and mitomycin C (FAM) or sequential chemotherapy with the same